Home » Clinical Trials » Medical Areas
Therapeutic Areas: Endocrinology
Disease Category: Diabetes Mellitus, Type 2
Trial Information
Type 2 Diabetes
The purpose of this research study is to examine the effectiveness of 2 different doses of an extended release investigational medication given by injection once a week. This is compared to a marketed daily oral medication compared to placebo when taken with metformin for treatment of Type II diabetes. If you are 18-75 years old, have Type 2 diabetes and are currently taking Glucophage® (metformin) you may be eligible to participate.
If you don't know your fasting blood sugar, or your A1C values, call us to consider being screened. We can give you some basic information about your values, and about this research study.
For more information, and to see if you qualify, call our office at 585.288.0890 or visit our website at www.rcrclinical.com.
Rochester Clinical Research
500 Helendale Road, Suite L20
Rochester NY 14609
Phone: 585-288-0890
EMail: volunteers@rcrclinical.com
View Google Map
Research Center Information: Rochester Clinical Research
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
